Clinical Trial

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare cisplatin-based with carboplatin-based chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of carboplatin-based chemoradiotherapy in NPC patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-04-14.
Trial Details
NCT Number NCT03919552
Lead Sponsor Nanfang Hospital, Southern Medical University
Conditions Cisplatin, Carboplatin, NPC
Enrollment 482 participants
Start Date 2018-01-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-06-18